• Return to Headlines

After Yesterday's Decline of 8.67%, Tandem Diabetes Offers Investors Better Value

By Shiri Gupta

Tandem Diabetes (NASDAQ:TNDM) traded in a range yesterday that spanned from a low of $63.02 to a high of $71.00. Yesterday, the shares fell 8.7%, which took the trading range below the 3-day low of $66.07 on volume of 2.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

SmarTrend recommended that subscribers consider buying shares of Tandem Diabetes on April 29th, 2019 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $63.42. Since that recommendation, shares of Tandem Diabetes have risen 8.9%. We continue to monitor TNDM for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Over the past year, Tandem Diabetes has traded in a range of $15.50 to $74.81 and is now at $63.28, 308% above that low. Over the past week, the 200-day moving average (MA) has gone up 1.3% while the 50-day MA has advanced 0.8%.

Keywords: rebounders tandem diabetes

Ticker(s): TNDM